Results: Our findings revealed that CD56+CD16+ and CD56−CD16− NK cells exhibited reduced cytotoxicity, mainly through HLA-E-expressing senescent cancer cells interacting with NK cells inhibitory receptor, leading to NK cell dysfunction and reduced XCL2 expression, which might impair cDC1 recruitment. This evidence concerns the gene NCAM1 and cancer.